Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Karyotyping

Karyotyping

Describing the number and physical features of chromosomes can reveal abnormalities that underlie genetic diseases. This description is facilitated by special staining techniques that produce a particular banding pattern on each chromosome. State-of-the-art techniques make this approach even more powerful, enabling the detection of individual genes that cause disease.A Simple Chromosome Staining Technique Provides Valuable Scientific InsightSome genetic diseases can be detected by looking at...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HPV16 genetic variation provides evidence of positive natural selection driven by HLA class I.

Nature communications·2026

Same author

Antiretroviral therapy blocks natural selection on protective and disease-susceptible HLA-B alleles in HIV-1 infection.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Specific combinations of human and viral genetic variants explain a cancer predisposition in southern China.

Nature·2026

Same author

Human genetics of HIV infection.

Current opinion in virology·2026

Same author

HLA Class II Protein Expression Regulation Is Strongly Linked to Cis-Acting SNPs.

HLA·2026

Same author

HLA class I signal peptide variation predicts strength of NKG2A<sup>+</sup> NK cell response to missing-self and risk of human disease.

Nature immunology·2026

Search research articles

Related Experiment Video

Updated: Jul 6, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

KIR locus polymorphisms: genotyping and disease association analysis.

Maureen P Martin¹, Mary Carrington

¹Laboratory of Genomic Diversity, SAIC-Frederick, Inc., NCI-Frederick, Frederick, MD, USA.

Methods in Molecular Biology (Clifton, N.J.)

|March 29, 2008

Summary

Killer immunoglobulin-like receptor (KIR) genes show significant variation due to DNA recombination. Analyzing KIR and human leukocyte antigen (HLA) gene combinations is crucial for understanding disease associations.

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Experiment Videos

Last Updated: Jul 6, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Area of Science:

Immunogenetics
Molecular biology
Population genetics

Background:

Killer immunoglobulin-like receptors (KIR) are immune receptors encoded by genes in a highly variable DNA region.
Unequal crossing over leads to significant differences in KIR gene content among individuals (haplotypic variation).
Human leukocyte antigen (HLA) class I molecules serve as ligands for KIR, exhibiting substantial allelic polymorphism.

Purpose of the Study:

To describe a genotyping method for identifying the presence or absence of KIR genes.
To outline general approaches for analyzing KIR and HLA gene data in disease association studies.
To emphasize the importance of considering functionally relevant KIR-HLA combinations in disease outcome research.

Main Methods:

Genotyping methods to determine KIR gene presence/absence.
Analysis of KIR gene content variation.
Consideration of KIR-HLA receptor-ligand interactions.
Approaches for disease association study data analysis.

Main Results:

Significant haplotypic variation in KIR gene content exists among individuals.
KIR genes display considerable allelic polymorphism, mirroring HLA polymorphism.
Functional KIR-HLA combinations are key for disease association studies.

Conclusions:

Understanding KIR gene variation and its interplay with HLA is essential for disease research.
Standardized genotyping and analysis methods are needed for KIR-HLA studies.
This work provides a foundation for investigating KIR-HLA associations with various disease outcomes.